Chronic inflammation has a crucial role in cancer development and the progression of various tumors, including pancreatic ductal adenocarcinoma (PDAC). The arachidonate cascade is a major inflammatory pathway that produces several metabolites, such as prostaglandin E2. The enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH) degrades prostaglandin and is frequently decreased in several types of cancer; however, the molecular mechanisms of 15-PGDH suppression are unclear. The current study was carried out to elucidate the molecular mechanisms and clinical significance of 15-PGDH suppression in PDAC. Here, we showed that interleukin1b (IL-1b), a pro-inflammatory cytokine, downregulates 15-PGDH expression in PDAC cells, and that IL-1b expression was inversely correlated with 15-PGDH levels in frozen PDAC tissues. We also found that activated macrophages produced IL-1b and reduced 15-PGDH expression in PDAC cells. Furthermore, the number of CD163-positive tumor-associated macrophages was shown to be inversely correlated with 15-PGDH levels in PDAC cells by immunohistochemical staining of 107 PDAC samples. Finally, we found that low 15-PGDH expression was significantly associated with advanced tumors, presence of lymph node metastasis and nerve invasion, and poor prognosis in PDAC patients. Our results indicate that IL-1b derived from TAMs suppresses 15-PGDH expression in PDAC cells, resulting in poor prognosis of PDAC patients.
stage, when this cancer is ineligible for complete surgical resection and is resistant to therapy.
1 Furthermore, recurrence is common even after complete resection and is usually only amenable to palliative chemotherapy. The principal risk factor of PDAC is chronic pancreatitis, which results in an approximately 13-fold increased risk for PDAC. 2 Chronic inflammation is implicated in the development of several cancers, including liver, stomach, colon, uterus, bladder, and pancreatic cancers. The relationships between hepatitis virus and hepatocellular carcinoma, Helicobacter pylori and gastric cancer, and human papilloma virus and cervical cancer have been confirmed by overwhelming evidence. [3] [4] [5] [6] [7] Therefore, anti-inflammatory agents such as aspirin, a COX inhibitor that blocks prostaglandin synthases, have been reported to reduce the risk of many cancers. 8, 9 Solid tumors are composed of cancer cells and diverse types of stromal cells, including cancer-associated fibroblasts and TAMs. [10] [11] [12] [13] Thus, tumor progression depends on not only the aggressive characteristics of cancer cells themselves but also on their interactions with stromal cells. A previous study reported that prostaglandin signal activation caused by TAMs promoted tumor metastasis. 14 In addition, prostaglandin signaling had an important role in gastric tumorigenesis through TAM recruitment. 15, 16 Given these reports, prostaglandin signaling in the arachidonate cascade likely has an impact on cancer progression in inflammatory environments.
Recently, 15-PGDH, which degrades prostaglandin, has attracted attention, and inhibition of 15-PGDH caused PGE 2 accumulation and promoted tissue regeneration in mice by expanding the tissue stem cell fraction. 17 Although 15-PGDH is known to be a tumor suppressor in colon, lung, and breast cancers, [18] [19] [20] 
| Cell lines, macrophages, and cell culture
The human PDAC cell lines PK-8 and S2-013 were obtained from the Japanese Collection of Research Bioresource Cell Bank (Ibaraki, Japan) and RIKEN Bioresource Center Cell Bank (Tsukuba, Japan).
The cell lines were cultured in RPMI-1640 supplemented with 10%
FBS. Cells were maintained at 37°C in a humidified atmosphere containing 5% CO 2 . Cells were tested and confirmed negative for mycoplasma before use. Macrophages were obtained from PBMCs as previously described. 21 For the direct and indirect co-culture assays, the cell lines and macrophages were cultured in RPMI-1640.
| Preparation of CM
We prepared CM from PK-8 cells and macrophages as previously described. 22 Briefly, PK-8 cells and macrophages were seeded (1 9 10 5 cells/mL) into 100-mm dishes. After 72 hours, the culture medium was transferred to centrifuge tubes and centrifuged at 3000 g for 5 minutes at room temperature. The supernatant was used as CM without being frozen. 
| Immunohistochemistry and scoring
Paraffin-embedded sections obtained from the PDAC patients were deparaffinized and soaked in distilled water. Sample processing and IHC procedures were performed as described below. Endogenous peroxidase activity was blocked using 3% hydrogen peroxide. Sections were incubated with diluted primary antibodies. Detection was undertaken with a biotin-free HRP enzyme-labeled polymer of the Envision Plus detection system (Dako, Tokyo, Japan). A positive reaction was visualized using diaminobenzidine solution followed by counterstaining with Mayer's hematoxylin. All IHC staining was scored blind by two investigators independently.
Immunohistochemical staining of 15-PGDH was scored based on both the intensity and the extent of cell staining. The average proportion of positively stained cells was estimated and given a percentage score on a scale from 1 to 6: 1, 0%-5%; 2, 6%-20%; 3, 21%-40%; 4, 41%-60%; 5, 61%-80%; and 6, 81%-100%. The average intensity of positively stained cells was given an intensity score from 0 to 3: 0, absent; 1, weak; 2, moderate; and 3, strong expression). The two scores were multiplied to characterize 15-PGDH expression as low (0-7) or high (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) 
| Enzyme-linked immunosorbent assay
Protein levels of IL-1ß were measured by ELISA (R&D Systems) in conditioned medium. The assay procedure was performed according to the manufacturer's protocol. Protein values were calculated as pg/mL.
| Flow cytometry
The protocol for analyzing CD68, CD163, and IL-1b by flow cytometry has been described in a previous study. 23 patients who had less than 12 months of follow-up after surgery because of an inability to perform an accurate survival analysis. Thus, we undertook the IHC analysis using primary tissues obtained from 107 PDAC patients ( Figure 1A) . Expression of 15-PGDH was detected in the cytoplasm in PDAC cells ( Figure 1B) . A high level of 15-PGDH was observed in 47 patients. We further assessed the relationship between 15-PGDH expression and clinicopathological factors of PDAC patients. Low 15-PGDH expression was significantly associated with advanced tumor stage (P = .004), presence of lymph node metastasis (P = .002), and presence of nerve invasion (P = .013) ( Table 1) . A Kaplan-Meier survival analysis revealed that low 15-PGDH expression was significantly associated with poor prognosis of relapse-free survival (P = .0464; Figure 1C ) and overall survival (P = .0461; Figure 1D ). These results suggested that low 15-PGDH expression in PDAC cells is correlated with tumor progression and poor prognosis in PDAC patients. Recent studies have indicated that TNF-a suppresses 15-PGDH expression in colorectal cancer 25 and that IL-1b also suppresses 15-PGDH expression in gastric cancer. 26 Thus, we examined the effect of these cytokines on 15-PGDH expression in PDAC cells. Consequently, we found that IL-1b treatment significantly suppressed 15-PGDH expression in the two types of PDAC cells; however, TNF-a treatment had no effect on 15-PGDH expression in PDAC cells (Figure 2E-G) . We next assessed the relationship between IL-1b and 15-PGDH expression in frozen PDAC tumor tissues from six patients 
| Activated macrophages produce IL-1b and decrease 15-PGDH expression in PDAC cells
A previous study showed that macrophages have a central role in inflammation, and activated macrophages produce many types of pro-inflammatory cytokines following exposure to Toll-like receptor agonists such as LPS. 27 We therefore hypothesized that activated macrophages produce IL-1b in the tumor microenvironment, and the concentration of IL-1b in the conditioned medium of PDAC cells and macrophages was examined by ELISA. Notably, we found that LPS-induced activated macrophages produced abundant IL-1b compared with PDAC cells or non-activated macrophages (Figure 3A) . We further investigated whether activated macrophages can alter 15-PGDH expression in PDAC cells using indirect co-culture assays. Western blot analysis revealed that only activated macrophages reduced 15-PGDH expression in PDAC cells, and non-activated macrophages did not show these changes (Figure 3B) . We also found that CM obtained from activated macrophages reduced 15-PGDH expression in PDAC cells, although CM from PK-8 and non-activated macrophages did not induce such changes ( Figure 3C ). Tumor-associated macrophages have been implicated in tumor progression, and CD163 was identified as a potent marker of TAMs. 28 Therefore, we confirmed that LPSinduced activated macrophages significantly increased CD163 expression compared with non-activated macrophages ( Figure 3D ).
Moreover, we also found that macrophages directly co-cultured with PDAC cells had higher CD163 expression than macrophages without co-culture ( Figure 3E ). We next assessed whether TAMs altered 15-PGDH expression through IL-1b secretion under direct co-culture conditions. The PDAC cells co-cultured with non-activated and activated macrophages had lower 15-PGDH expression levels than PDAC cells alone ( Figure 3F ,G). We further assessed whether IL-1b was predominantly expressed in TAMs under direct co-culture conditions using flow cytometry analysis. As a result, we observed that, under direct co-culture conditions, IL-1b is more highly expressed in TAMs than in PK-8 cells ( Figure 3H ,I,S1). These results suggest that activated macrophages secrete abundant IL-1b and suppress 15-PGDH expression in PDAC cells.
| Number of infiltrating TAMs is inversely correlated with 15-PGDH expression in PDAC cells
Given that TAMs secrete IL-1b and suppress 15-PGDH expression in PDAC cells in vitro, we further investigated the relationship between
15-PGDH expression in PDAC cells and the number of infiltrating
TAMs in human PDAC tissues. We examined CD163 expression using IHC analysis to detect infiltrating TAMs in 107 human PDAC samples ( Figure 4A,B) , and the median number of TAMs was 20 cells/high-power field (range, 2-42 cells/high-powered field).
Consequently, the number of infiltrating TAMs was found to be inversely correlated with 15-PGDH expression, in agreement with 
| DISCUSSION
Cancer-related inflammation has been shown to promote tumor growth and progression in diverse cancers, including PDAC. 29 The arachidonate cascade, a major inflammatory pathway, produces several metabolites due to activation of COX, and tumors harboring high COX expression have been associated with poor prognosis of patients with various types of cancer. 30 Furthermore, 15-PGDH is the key enzyme responsible for degradation and biological inactivation of PGE 2 ; thus, decreased 15-PGDH expression leads to PGE 2 accumulation in the cells. According to previous studies, HPGD has been reported to be a tumor suppressor gene in several types of cancer. [18] [19] [20] Here, we showed that 15-PGDH expression in PDAC cells is sup- 
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